DuPont Reports 4Q and Full-Year 2012 EPS of $.11 and $3.33 Ex-items

Tue Jan 22, 2013 6:00am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130122:nPnPH45786

Expects Modest Growth in 2013 Operating Earnings


WILMINGTON, Del.,  Jan. 22, 2013  /PRNewswire/ --

Fourth Quarter:

* Fourth quarter 2012 earnings per share (EPS) from continuing operations,
excluding significant items,  was  $.11  versus prior year earnings of  $.26. 
Reported fourth quarter 2012 EPS from continuing  operations was  $.02  versus 
$.31  in the prior year.


* Sales of  $7.3 billion  equaled the prior year.  Three percent higher volume
was offset by 2 percent  negative currency impact and a 1 percent reduction from
portfolio changes.   


* Segment pre-tax operating income (PTOI) was down, primarily reflecting lower
price and volume in Performance Chemicals.  Titanium dioxide pricing led the
decline.

Full Year:

* 2012 EPS from continuing operations, excluding significant items, was  $3.33 
versus  $3.55  in 2011.  Currency was a  $.27  per share headwind for the year. 
Reported EPS from continuing operations was  $2.61  versus  $3.30  in 2011 (see
Schedule B.)


* Sales were  $34.8 billion, up 3 percent with a 6 percent increase in
developing markets.  


* Segment PTOI increased 3 percent to  $5.7 billion, excluding Pharmaceuticals
and significant items.  Agriculture PTOI increased 18 percent driven by volume
and pricing growth for seed and crop protection businesses in  North America 
and Latin America.  Performance Chemicals PTOI decreased 16 percent from lower
sales across the segment.


* Free cash flow was  $3.1 billion  versus  $3.3 billion  in the prior year. 
2012 includes a  $0.5 billion  contribution to the principal U.S. pension plan
and lower net income, partly offset by improved working capital productivity.  


* Fixed cost and working capital productivity benefits were each about  $400
million, surpassing their  
$300 million  targets.


* Reflecting the change in reporting for the cost of non-operating pension and
other post-employment benefits and excluding significant items, 2012 operating
earnings were  $3.77  per share.  On the same basis, the 2013 outlook for
operating earnings is  $3.85 to $4.05  per share, an increase of 2 to 7 percent
over the prior year.

"DuPont stands stronger today than it did a year ago.  Our segments delivered
innovation, productivity and integration cost synergies.  This, coupled with a
record year in new product introductions, has strengthened our market position,"
said DuPont Chair and CEO  Ellen Kullman.  "However, weakness in markets served
by Performance Chemicals and Electronics & Communications provided significant
challenges in 2012.  We've adjusted our plans to meet the changing market
environment and grow our businesses in a slow-growth world economy."

Global Consolidated Sales  - 4th  Quarter
Fourth quarter 2012 sales were  $7.3 billion, flat versus the prior year. 
Currency impact and portfolio changes offset 3 percent volume growth.  Volume
was driven by Agriculture, with robust sales in  Latin America  and a strong
start to the North American selling season, and increases in  Asia Pacific  for
Performance Materials, Electronics & Communications and Performance Chemicals. 
The table below shows fourth quarter regional sales and variances versus fourth
quarter 2011.

                             Three Months Ended                Percentage Change Due to:                                            
                             December 31, 2012                                                                                      
 (Dollars in billions)       $                   % Change    Local         Currency Effect        Volume        Portfolio/  
                                                             
Price                                             
Other      
 U.S. & Canada               $     2.5           -           2             -                      -             (2)         
 EMEA*                       1.6                 (8)         (1)           (4)                    (2)           (1)         
 Asia Pacific                1.9                 -           (5)           (1)                    6             -           
 Latin America               1.3                 10          7             (4)                    8             (1)         
                                                                                                                            
                                                                                                                            
 Total Consolidated Sales    $     7.3           -           -             (2)                    3             (1)         


Global Consolidated Sales - Full-Year
Full-year 2012 sales were  $34.8 billion, up 3 percent versus 2011, reflecting 4
percent higher local prices, 2 percent adverse currency impact, 2 percent lower
volume, and a 3 percent net increase from portfolio changes.  Local prices
increased for all segments except Electronics & Communications which had lower
pass-through of metals prices.  Lower global volume principally reflects
decreases for Performance Chemicals and Electronics & Communications, partly
offset by higher Agriculture volumes.  The table below shows regional sales and
variances versus 2011.

                                     Year Ended                        Percentage Change Due to:                                            
                                     December 31, 2012                                                                                      
 (Dollars in billions)               $                   % Change    Local         Currency Effect        Volume        Portfolio/  
                                                                     
Price                                             
Other      
 U.S. & Canada                       $   14.2            8           6             -                      -             2           
 EMEA*                               8.1                 (1)         3             (6)                    (4)           6           
 Asia Pacific                        8.0                 (4)         (1)           (1)                    (5)           3           
 Latin America                       4.5                 11          9             (5)                    5             2           
                                                                                                                                    
                                                                                                                                    
 Total Consolidated Sales            $   34.8            3           4             (2)                    (2)           3           
                                                                                                                                    
                                                                                                                                    
 * Europe, Middle East & Africa                                                                                                        


Income from Continuing Operations - 4th  Quarter
Excluding significant items, fourth quarter 2012 income from continuing
operations was  $110 million  versus  $246 million  in the prior year.  The
decrease principally reflects lower income from Performance Chemicals and
Pharmaceuticals, increased spending for growth initiatives and adverse currency
impact.  Reported fourth quarter 2012 income from continuing operations was  $19
million  versus  $293 million  in the fourth quarter 2011.  

Earnings Per Share - 4th  Quarter
The table below shows year-over-year earnings per share (EPS) variances for the
fourth quarter.

                                                                   
 EPS  ANALYSIS                                                        
                                                                   
                                                 4Q                
                                                                   
 EPS 2011                                        $.31              
 Less: Significant items - (schedule B)          .05               
                                                                   
 EPS 2011 -Excluding significant items           .26               
                                                                   
 Local prices                                    (.01)             
 Variable cost*                                  .12               
 Volume                                          (.03)             
 Fixed cost*                                     (.12)             
 Currency                                        (.04)             
 Income tax                                      .04               
 Pharmaceuticals income                          (.06)             
 Other**                                         (.05)             
                                                                   
 EPS 2012 - Excluding significant items          $.11              
 Add: Significant items - (schedule B)           (.09)             
                                                                   
 EPS 2012                                        $.02              
                                                                   
                                                                   
 *  Excludes volume and currency impacts                              
 ** Includes interest expense, net exchange gains/losses, and other income 
                                                                      
                                                                


Business Segment Performance - 4th  Quarter
The tables below show fourth quarter 2012 segment sales with  related variances
versus the prior year and fourth quarter PTOI excluding significant items.

 SEGMENT SALES*                Three Months Ended                   Percentage Change                           
 (Dollars in billions)         December 31, 2012                Due to:                             
                               $                    % Change      USD           Volume        Portfolio   
                                                                  
Price                      
and Other  
 Agriculture                   $      1.5           18            7             11            -           
 Electronics & Communications  0.6                  (1)           (3)           2             -           
 Industrial Biosciences        0.3                  4             1             3             -           
 Nutrition & Health            0.9                  6             3             3             -           
 Performance Chemicals         1.6                  (15)          (7)           (8)           -           
 Performance Materials         1.5                  (5)           (5)           3             (3)         
 Safety & Protection           1.0                  2             (1)           3             -           
                                                                                                                   
 *    Segment sales include transfers                                                                              


 SEGMENT PTOI excluding Significant Items*                                                                       Change versus 2011                 
 (Dollars in millions)                                         4Q 2012                 4Q 2011                 $                       %        
                                                                                                                                                
 Agriculture                                                   $     (92)              $   (116)               $      24               21%      
 Electronics & Communications                                  24                      42                      (18)                    -43%     
 Industrial Biosciences                                        44                      34                      10                      29%      
 Nutrition & Health                                            66                      52                      14                      27%      
 Performance Chemicals                                         200                     433                     (233)                   -54%     
 Performance Materials                                         254                     151                     103                     68%      
 Safety & Protection                                           88                      94                      (6)                     -6%      
 Other                                                         (71)                    (74)                    3                       nm       
                                                               $     513               $     616               $   (103)               -17%     
 Pharmaceuticals                                               9                       89                      (80)                    -90%     
 Total Segment PTOI                                            $     522               $     705               $   (183)               -26%     
                                                                                                                                                
 * See Schedules B and C for listing of significant items and their impact by segment.                                                                  


Business Segment Performance - Full Year
The tables below show full-year 2012 segment sales with related variances versus
the prior year, and full-year PTOI excluding significant items.

                               12 Months Ended                    Percentage Change                           
 SEGMENT SALES*                December 31, 2012              Due to:                             
 (Dollars in billions)                                                                                           
                               $                  % Change      USD           Volume        Portfolio   
                                                                
Price                      
and Other  
 Agriculture                   $    10.4          14            6             8             -           
 Electronics & Communications  2.7                (15)          (4)           (11)          -           
 Industrial Biosciences        1.2                67            (4)           8             63          
 Nutrition & Health            3.4                39            1             3             35          
 Performance Chemicals         7.2                (8)           4             (12)          -           
 Performance Materials         6.4                (5)           (2)           -             (3)         
 Safety & Protection           3.8                (3)           -             (3)           -           
                                                                                                                 
 *    Segment sales include transfers                                                                            


 SEGMENT PTOI excluding Significant Items*                                                                      
 (Dollars in millions)                                                        Change versus 2011                
                                               FY 2012           FY 2011      $                      %        
                                                                                                              
 Agriculture                                   $  2,063          $   1,752    $      311             18%      
 Electronics & Communications                  172               355          (183)                  -52%     
 Industrial Biosciences                        171               78           93                     119%     
 Nutrition & Health                            348               170          178                    105%     
 Performance Chemicals                         1,622             1,923        (301)                  -16%     
 Performance Materials                         1,117             924          193                    21%      
 Safety & Protection                           418               500          (82)                   -16%     
 Other                                         (259)             (235)        (24)                   nm       
                                               $  5,652          $   5,467    $      185             3%       
 Pharmaceuticals                               62                289          (227)                  -79%     
 Total Segment PTOI                            $  5,714          $   5,756    $       (42)           -1%      
                                                                                                              
 * See Schedules B and C for listing of significant items and their impact by segment.                                


The following is a summary of business results for each of the company's
reportable segments in the fourth quarter (unless otherwise noted), comparing
current period with the prior year, for sales and PTOI (loss) excluding
significant items.  References to selling price are on a U.S. dollar basis,
including the impact of currency.

Agriculture -  Sales of  $1.5 billion  were up 18 percent on 11 percent higher
volume and 7 percent higher prices despite the negative impact of currency. 
PTOI seasonal loss of  ($92) million  improved  $24 million  on higher volume in
 Latin America  and stronger than expected pricing gains, partially offset by
continued investment in commercial and R&D activities.   

Full-year sales of  $10.4 billion  grew 14 percent on 8 percent higher volume
and 6 percent higher prices.  Pioneer seed sales increased from higher global
volume and pricing gains in corn and soybeans.  Crop Protection sales grew on
strong demand for insecticides and herbicides in all regions.  Full-year PTOI
increased 18 percent as strong sales more than offset unfavorable currency and
higher investments in commercial and R&D activities to support growth.    

Electronics & Communications -  Sales of  $622 million  were down 1 percent,
with 2 percent higher volume offset by
3 percent lower prices, primarily pass-through of lower metals prices.  Volume
growth from increased demand for materials in smart phones and tablets was
partly offset by continued softness in photovoltaic materials.  PTOI declined 
$18 million  as the prior year included OLED technology licensing income of  $20
million.

Industrial Biosciences -  Sales of  $300 million  were up 4 percent on 3 percent
higher volume and 1 percent higher prices.  Volume growth reflects strong sales
of Sorona®  polymer for carpeting, and continued growth in food enzymes in
Europe.  PTOI of  $44 million  was up  $10 million  on higher volume and the
benefit of synergies realized from the integration of the Danisco enzyme
business.

Nutrition &  Health  -Sales of  $853 million  were up 6 percent on 3 percent
higher volume and 3 percent higher prices.  Volume growth reflects strong demand
for probiotics, cultures and enablers.  Higher local prices in all regions were
partly offset by unfavorable currency.  PTOI of  $66 million  was up  $14
million  on higher sales and the benefit of synergies realized from the
integration of the Danisco specialty food ingredients business, partly offset by
higher raw material costs.

Performance Chemicals -  Sales of  $1.6 billion  were down 15 percent, with 8
percent lower volume and 7 percent lower prices.  Lower volume resulted
primarily from weak demand for fluoropolymers in U.S. and Europe.  Lower prices
reflect cyclical pressure in the titanium dioxide market.  PTOI of  $200 million
 decreased  $233 million  on lower sales and plant utilization in both
businesses.  

Performance Materials -  Sales of  $1.5 billion  were down 5 percent, with 5
percent lower prices and a 3 percent reduction from a portfolio change, partly
offset by 3 percent higher volume.  Stable packaging markets and strong demand
in the North American automotive market were partially offset by softness in the
industrial and electronics markets and a weak Europe.  PTOI of  $254 million 
increased  $103 million  due to lower feedstock costs, higher volume and mix
enrichment, partly offset by unfavorable currency.   

Safety & Protection -  Sales of  $964 million  were up 2 percent on 3 percent
higher volume, partly offset by 1 percent lower prices due to unfavorable
currency.  Volume increased on higher demand for Sustainable Solutions offerings
and U.S. residential and commercial construction products.  PTOI of  $88 million
 decreased  $6 million  primarily due to lower plant utilization related to
softness in certain industrial markets and U.S. public sector markets.   

Additional information is available on the DuPont Investor Center website at 
http://www.investors.dupont.com.

Outlook  
Reflecting the change in reporting for the cost of non-operating pension and
other post-employment benefits and excluding significant items, 2012 operating
earnings were  $3.77  per share.  On the same basis, the 2013 outlook for
operating earnings is  $3.85 to $4.05  per share, an increase of 2 to 7 percent
over the prior year. First half 2013 operating earnings are expected to decline
modestly on a year-over-year basis.  Additionally, full-year 2013 sales are
expected to be about  $36 billion.

Use of Non-GAAP Measures  
Management believes that certain non-GAAP measurements are meaningful to
investors because they provide insight with respect to ongoing operating results
of the company.  Such measurements are not recognized in accordance with
generally accepted accounting principles (GAAP) and should not be viewed as an
alternative to GAAP measures of performance.  Reconciliations of non-GAAP
measures to GAAP are provided in schedules C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802.  The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such global
challenges as providing enough healthy food for people everywhere, decreasing
dependence on fossil fuels, and protecting life and the environment.  For
additional information about DuPont and its commitment to inclusive innovation,
please visit  http://www.dupont.com.

Forward-Looking Statements:  This news release contains forward-looking
statements which may be identified by their use of words like "plans,"
"expects," "will," "believes," "intends," "estimates" or other words of similar
meaning.  All statements that address expectations or projections about the
future, including statements about the company's growth strategy, product
development, regulatory approval, market position, anticipated benefits of
acquisitions, outcome of contingencies, such as litigation and environmental
matters, expenditures and financial results, are forward-looking statements. 
Forward-looking statements are not guarantees of future performance and are
based on certain assumptions and expectations of future events which may not be
realized.  Forward-looking statements also involve risks and uncertainties, many
of which are beyond the company's control.  Some of the important factors that
could cause the company's actual results to differ materially from those
projected in any such forward-looking statements are: fluctuations in energy and
raw material prices; failure to develop and market new products and optimally
manage product life cycles; significant litigation and environmental matters;
failure to appropriately manage process safety and product stewardship issues;
changes in laws and regulations or political conditions; global economic and
capital markets conditions, such as inflation, interest and currency exchange
rates; business or supply disruptions; security threats, such as acts of
sabotage, terrorism or war, weather events and natural disasters; inability to
protect and enforce the company's intellectual property rights; and integration
of acquired businesses and completion of divestitures of underperforming or
non-strategic assets or businesses.  The company undertakes no duty to update
any forward-looking statements as a result of future developments or new
information.

 E. I. du Pont de Nemours and Company                                                                                                                                                                                                                                        
 
Consolidated Income Statements                                                                                                                                                                                                                                             
 
(Dollars in millions, except per share amounts)                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                             
 SCHEDULE A                                                                                                                                                                                                                                                             
                                                                                                                                                                     Three Months Ended                                  Year Ended                                     
                                                                                                                                                                     December 31,                                        December 31,                                   
                                                                                                                                                                   2012                        2011                  2012                      2011               
 Net sales                                                                                                                                                         $          7,325            $          7,343      $        34,812           $        33,681    
 Other income, net(a)                                                                                                                                              247                         338                   498                       742                
 Total                                                                                                                                                             7,572                       7,681                 35,310                    34,423             
                                                                                                                                                                                                                                                                  
 Cost of goods sold and other operating charges  (a)                                                                                                               5,983                       5,927                 25,604                    24,874             
 Selling, general and administrative expenses                                                                                                                      842                         791                   3,567                     3,358              
 Research and development expense  (a)                                                                                                                             547                         527                   2,067                     1,910              
 Interest expense                                                                                                                                                  117                         116                   464                       447                
 Employee separation / asset related charges, net  (a)                                                                                                             99                          17                    493                       53                 
 Total                                                                                                                                                             7,588                       7,378                 32,195                    30,642             
                                                                                                                                                                                                                                                                  
 (Loss) income from continuing operations before income taxes                                                                                                      (16)                        303                   3,115                     3,781              
 (Benefit from) provision for income taxes on continuing operations                                                                                                (35)                        10                    622                       626                
 Income from continuing operations after income taxes                                                                                                              19                          293                   2,493                     3,155              
 Net income from discontinued operations after taxes                                                                                                               93                          84                    320                       355                
                                                                                                                                                                                                                                                                  
 Net income                                                                                                                                                        112                         377                   2,813                     3,510              
                                                                                                                                                                                                                                                                  
 Less:   Net income attributable to noncontrolling interests                                                                                                       1                           4                     25                        36                 
                                                                                                                                                                                                                                                                  
 Net income attributable to DuPont                                                                                                                                 $             111           $             373     $          2,788          $          3,474   
                                                                                                                                                                                                                                                                  
 Basic earnings per share of common stock  (b):                                                                                                                                                                                                                   
 Basic earnings per share of common stock from continuing operations                                                                                               $            0.02           $            0.31     $            2.63         $            3.35  
 Basic earnings per share of common stock from discontinued operations                                                                                             0.10                        0.09                  0.34                      0.38               
 Basic earnings per share of common stock                                                                                                                          $            0.12           $            0.40     $            2.98         $            3.73  
                                                                                                                                                                                                                                                                  
 Diluted earnings per share of common stock  (b):                                                                                                                                                                                                                 
 Diluted earnings per share of common stock from continuing operations                                                                                             $            0.02           $            0.31     $            2.61         $            3.30  
 Diluted earnings per share of common stock from discontinued operations                                                                                           0.10                        0.09                  0.34                      0.38               
 Diluted earnings per share of common stock                                                                                                                        $            0.12           $            0.40     $            2.95         $            3.68  
                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                  
 Dividends per share of common stock                                                                                                                               $            0.43           $            0.41     $            1.70         $            1.64  
                                                                                                                                                                                                                                                                  
 Average number of shares outstanding used in earnings per share (EPS) calculation:                                                                                                                                                                               
 Basic                                                                                                                                                             933,420,000                 925,588,000           933,275,000               928,417,000        
 Diluted                                                                                                                                                           941,219,000                 935,709,000           942,197,000               941,029,000        
                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                  
 (a) See Schedule B for detail of significant items.                                                                                                                                                                                                                
 (b) The sum of the individual earnings per share amounts may not equal the total due to rounding.                                                                                                                                                                     


 E. I. du Pont de Nemours and Company                                                                                                
 
Condensed Consolidated Balance Sheets                                                                                              
 
(Dollars in millions, except per share amounts)                                                                                    
                                                                                                                                     
 SCHEDULE A (continued)                                                                                                            
                                                                                        December 31,          December 31,       
                                                                                        2012                  2011               
 Assets                                                                                                                          
 Current assets                                                                                                                  
 Cash and cash equivalents                                                              $           4,284     $           3,586  
 Marketable securities                                                                  123                   433                
 Accounts and notes receivable, net                                                     5,452                 6,022              
 Inventories                                                                            7,422                 7,195              
 Prepaid expenses                                                                       204                   151                
 Deferred income taxes                                                                  650                   671                
 Assets held for sale                                                                   3,056                 -                  
 Total current assets                                                                   21,191                18,058             
 Property, plant and equipment,  net of accumulated depreciation                        12,741                13,412             
     (December 31, 2012 - $19,085; December 31, 2011 - $19,349)                                                                  
 Goodwill                                                                               4,616                 5,413              
 Other intangible assets                                                                5,126                 5,413              
 Investment in affiliates                                                               1,163                 1,117              
 Deferred income taxes                                                                  3,939                 4,067              
 Other assets                                                                           960                   1,012              
 Total                                                                                  $         49,736      $         48,492   
                                                                                                                                 
 Liabilities and Equity                                                                                                          
 Current liabilities                                                                                                             
 Accounts payable                                                                       $           4,853     $           4,816  
 Short-term borrowings and capital lease obligations                                    1,275                 817                
 Income taxes                                                                           340                   255                
 Other accrued liabilities                                                              5,997                 5,297              
 Liabilities related to assets held for sale                                            1,084                 -                  
 Total current liabilities                                                              13,549                11,185             
 Long-term borrowings and capital lease obligations                                     10,465                11,736             
 Other liabilities                                                                      14,687                15,508             
 Deferred income taxes                                                                  856                   1,001              
 Total liabilities                                                                      39,557                39,430             
                                                                                                                                 
 Commitments and contingent liabilities                                                                                          
                                                                                                                                 
 Stockholders' equity                                                                                                            
 Preferred stock                                                                        237                   237                
 Common stock, $0.30 par value; 1,800,000,000 shares authorized;                        306                   304                
     Issued at December 31, 2012 - 1,020,057,000; December 31, 2011 - 1,013,164,000                                              
 Additional paid-in capital                                                             10,632                10,107             
 Reinvested earnings                                                                    14,286                13,422             
 Accumulated other comprehensive loss                                                   (8,646)               (8,750)            
 Common stock held in treasury, at cost (87,041,000 shares                              (6,727)               (6,727)            
     at December 31, 2012 and 2011)                                                                                              
 Total DuPont stockholders' equity                                                      10,088                8,593              
 Noncontrolling interests                                                               91                    469                
 Total equity                                                                           10,179                9,062              
 Total                                                                                  $         49,736      $         48,492   
                                                                                                                                 


 E. I. du Pont de Nemours and Company                                                     
 
Condensed Consolidated Statement of Cash Flows                                          
 
(Dollars in millions, except per share amounts)                                         
                                                                                       
 SCHEDULE A (continued)                                                                  
                                                              Year Ended                 
                                                              December 31,               
 Total Company                                                2012            2011     
                                                                                       
 Cash provided by (used for) operating activities             $ 4,849         $ 5,152  
                                                                                       
 Investing activities                                                                  
 Purchases of property, plant and equipment                   (1,793)         (1,843)  
 Investments in affiliates                                    (97)            (67)     
 Payments for businesses (net of cash acquired)               (18)            (6,459)  
 Net (increase) decrease in short-term financial instruments  315             2,149    
 Proceeds from sales of assets - net of cash sold             302             214      
 Other investing activities - net                             (55)            (232)    
 Cash provided by (used for) investing activities             (1,346)         (6,238)  
                                                                                       
 Financing activities                                                                  
 Dividends paid to stockholders                               (1,594)         (1,533)  
 Net increase (decrease) in borrowings                        (793)           1,561    
 Repurchase of common stock                                   (400)           (672)    
 Proceeds from exercise of stock options                      550             952      
 Payments for noncontrolling interest                         (470)           -        
 Other financing activities - net                             10              95       
 Cash provided by (used for) financing activities             (2,697)         403      
                                                                                       
 Effect of exchange rate changes on cash                      (13)            6        
                                                                                       
 Cash classified as held for sale                             (95)            -        
                                                                                       
 Increase (decrease) in cash and cash equivalents             698             (677)    
                                                                                       
 Cash and cash equivalents at beginning of period             3,586           4,263    
                                                                                       
 Cash and cash equivalents at end of period                   $ 4,284         $ 3,586  
                                                                                       


 E. I. du Pont de Nemours and Company                                                                                                                                        
 
Schedule of Significant Items from Continuing Operations                                                                                                                   
 
(Dollars in millions, except per share amounts)                                                                                                                            
                                                                                                                                                                 
 SCHEDULE B                                                                                                                                                       
 SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS                                                                                                                        
                                                                                                                                                                 
                                                                    Pre-tax                              After-tax                      ($ Per Share)                  
                                                                    2012                  2011         2012            2011         2012             2011        
 1st Quarter                                                                                                                                                      
 Customer claims charge  (a)                                         $   (50)              $       -    $   (32)        $       -    $ (0.04)         $        -  
 1st Quarter - Total                                                 $   (50)              $       -    $   (32)        $       -    $ (0.04)         $        -  
 2nd Quarter                                                                                                                                                      
 Customer claims charge  (a)                                         $ (265)               $     -      $ (169)         $     -      $ (0.18)         $      -    
 Litigation settlement  (b)                                          (137)                 -            (123)           -            (0.13)           -           
 Gain on the sale of equity                                                                                                                                       
                        method investment  (c)                      122                   -            77              -            0.08             -           
 Transition costs related to the                                                                                                                                  
                        acquisition of Danisco(d)                   -                     (103)        -               (81)         -                (0.08)      
 2nd Quarter - Total                                                 $ (280)               $ (103)      $ (215)         $   (81)     $ (0.23)         $ (0.08)    
 3rd Quarter                                                                                                                                                      
 Customer claims charge  (a)                                         $ (125)               $   (75)     $   (80)        $   (48)     $ (0.09)         $ (0.05)    
 Restructuring charge  (e)                                           (152)                 -            (105)           -            (0.11)           -           
 Asset impairment charge  (f)                                        (242)                 -            (157)           -            (0.17)           -           
 Transition costs and restructuring charge                                                                                                                        
                        related to the acquisition of Danisco  (g)  -                     (171)        -               (122)        -                (0.13)      
 Charge related to milestone payment                                                                                                                              
                        for licensing agreement  (h)                -                     (50)         -               (33)         -                (0.03)      
 3rd Quarter - Total                                                 $ (519)               $ (296)      $ (342)         $ (203)      $ (0.37)         $ (0.21)    
                                                                                                                                                                 
 4th Quarter                                                                                                                                                      
 Customer claims charge  (a)                                         $ (135)               $ (100)      $   (89)        $   (64)     $ (0.09)         $ (0.07)    
 Restructuring charge/adjustments  (i)                               (66)                  (17)         (56)            (11)         (0.06)           (0.01)      
 Asset impairment charge  (j)                                        (33)                  -            (21)            -            (0.02)           -           
 Gain on sale of business  (k)                                       117                   -            75              -            0.08             -           
 Sale of a business  (l)                                             -                     49           -               122          -                0.13        
 4th Quarter - Total                                                 $ (117)               $   (68)     $   (91)        $    47      $ (0.09)         $  0.05     
                                                                                                                                                                 
 Full Year - Total  (m)                                              $ (966)               $ (467)      $ (680)         $ (237)      $ (0.72)         $ (0.25)    
                                                                                                                                                                 
                                                                                                                                                                 


 E. I. du Pont de Nemours and Company                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 
Schedule of Significant Items from Continuing Operations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 
(Dollars in millions, except per share amounts)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 SCHEDULE B (continued)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (a)         Fourth quarter 2012, third quarter 2012, second quarter 2012, first quarter 2012, fourth quarter 2011, and third quarter 2011 included charges of $(135), $(125), $(265), $(50), $(100), and $(75), respectively, recorded in Cost of goods sold and other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis herbicide, bringing the total charges to $(750) at December 31, 2012.   The company will continue to evaluate reported claim damage as additional information becomes available. It is reasonably possible that additional charges could result from this evaluation. While there is a high degree of uncertainty, total charges could range as high as $(900). The company has an applicable insurance program with a deductible equal to the first $100 of costs and expenses. The insurance program limits are $725 for costs and expenses in excess of the $100. The company has submitted, and will continue to submit, requests for payment to its insurance carriers for costs associated    
             with this matter.   This matter relates to the Agriculture segment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (b)         Second quarter 2012 included a charge of $(137) recorded in Cost of goods sold and other operating charges primarily related to the company's settlement of litigation with Invista.   This matter is included in Other.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (c)         Second quarter 2012 included a pre-tax gain of $122 recorded in Other income, net associated with the sale of an equity method investment in the Electronics & Communications segment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (d)         Second quarter 2011 included charges related to the Danisco acquisition of $(103) recorded in Cost of goods sold and other operating charges.   These charges included $(60) of transaction costs and a $(43) charge related to the fair value step-up of inventories that were acquired from Danisco and sold in the second quarter 2011. Pre-tax charges by segment were: Industrial Biosciences - $(17), Nutrition & Health - $(33), and Corporate expenses - $(53).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (e)         Third quarter 2012 included a $(152) restructuring charge recorded in Employee separation/asset related charges, net consisting of $(133) of severance and related benefit costs and $(19) of asset related charges as a result of the company's plan to eliminate corporate costs previously allocated to Performance Coatings and cost-cutting actions to improve competitiveness.   Pre-tax charges by segment were: Agriculture - $(3), Nutrition & Health - $(13), Electronics & Communications - $(7), Performance Chemicals - $(3), Performance Materials - $(9), Safety & Protection - $(55), Industrial Biosciences - $(3), and Corporate expenses - $(59).                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (f)         Third quarter 2012 included a $(242) impairment charge recorded in Employee separation/asset related charges, net related to asset groupings within the Electronics & Communications and Performance Materials segments. The charge of $(150) within Electronics & Communications was a result of conditions within the thin film photovoltaic market. The charge of $(92) within Performance Materials was the result of deteriorating conditions in an industrial polymer market.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (g)         Third quarter 2011 included charges related to the Danisco acquisition of $(171).   These charges included $(135) recorded in Cost of goods sold and other operating charges for $(3) of transaction costs and a $(132) charge related to the fair value step-up of inventories that were acquired from Danisco and sold in the third quarter 2011.   These charges also included a $(36) restructuring charge recorded in Employee separation / asset related charges, net related to severance and related benefit costs.   Pre-tax charges by segment were: Industrial Biosciences - $(61), Nutrition & Health - $(89), Other - $(18), and Corporate expenses - $(3).                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (h)         Third quarter 2011 included a ($50) charge recorded in Research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (i)         Fourth quarter 2012 included a $(66) restructuring charge recorded in Employee separation/asset related charges, net primarily as a result of the company's plans to eliminate corporate costs previously allocated to Performance Coatings and cost-cutting actions to improve competitiveness, partially offset by a reversal of prior year restructuring accruals. Pre-tax charges by segment are: Agriculture - $(8), Electronics & Communications - $(2), Nutrition & Health - $(36), Performance Materials - $(3), Safety & Protection - $(3), Other - $11, and Corporate expenses - $(25). Fourth quarter 2011 included a $(17) restructuring charge recorded in Employee separation/asset related charges, net primarily related to severance and related benefit costs associated with the Danisco acquisition, partially offset by a reversal of prior year restructuring accruals.   Pre-tax charges by segment were: Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), and Other - $(10).                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (j)         Fourth quarter 2012 included a $(33) impairment charge recorded in Employee separation/asset related charges, net related to an asset group within the Performance Chemicals segment.   The charge was a result of strategic decisions related to deteriorating conditions within a specific industrial chemicals market.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (k)         Fourth quarter 2012 included a pre-tax gain of $117 recorded in Other income, net associated with the sale of a business within the Agriculture segment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (l)         Fourth quarter 2011 included a pre-tax gain of $49 recorded in Other income, net associated with the sale of a business in the Performance Materials segment and a related tax benefit of $73.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 (m)         Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 See Schedule C for detail by segment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 


 E. I. du Pont de Nemours and Company                                                                                                     
 
Consolidated Segment Information                                                                                                        
 
(Dollars in millions)                                                                                                                   
                                                                                                                                
 SCHEDULE C                                                                                                                           
                                                                 Three Months Ended                    Year Ended                    
                                                                 December 31,                          December 31,                  
 SEGMENT SALES  (1)                                             2012                  2011          2012             2011       
 Agriculture                                                    $ 1,535               $ 1,297       $ 10,426         $   9,166  
 Electronics & Communications                                   622                   630           2,701            3,173      
 Industrial Biosciences                                         300                   289           1,180            705        
 Nutrition & Health                                             853                   806           3,422            2,460      
 Performance Chemicals                                          1,588                 1,860         7,188            7,794      
 Performance Materials                                          1,534                 1,618         6,447            6,815      
 Safety & Protection                                            964                   943           3,825            3,934      
 Other                                                          1                     1             5                40         
 Total Segment sales                                            7,397                 7,444         35,194           34,087     
                                                                                                                                
 Elimination of transfers                                       (72)                  (101)         (382)            (406)      
 Consolidated net sales                                         $ 7,325               $ 7,343       $ 34,812         $ 33,681   
                                                                                                                                
                                                                                                                                
 (1)    Sales for the reporting segments include transfers.                                                                           


 E. I. du Pont de Nemours and Company                                                                                                                         
 
Consolidated Segment Information                                                                                                                            
 
(Dollars in millions)                                                                                                                                       
                                                                                                                                                      
 SCHEDULE C (continued)                                                                                                                                     
                                                                                 Three Months Ended                          Year Ended                   
                                                                                 December 31,                                December 31,                 
 PRE-TAX OPERATING INCOME/(LOSS) (PTOI) FROM CONTINUING OPERATIONS               2012                      2011            2012             2011      
 Agriculture                                                                     $ (118)                   $ (216)         $ 1,594          $ 1,527   
 Electronics & Communications                                                    22                        42              135              355       
 Industrial Biosciences                                                          44                        33              168              (1)       
 Nutrition & Health                                                              30                        48              299              44        
 Performance Chemicals                                                           167                       433             1,586            1,923     
 Performance Materials                                                           251                       198             1,013            971       
 Safety & Protection                                                             85                        94              360              500       
 Pharmaceuticals                                                                 9                         89              62               289       
 Other                                                                           (60)                      (84)            (385)            (263)     
 Total Segment PTOI                                                              430                       637             4,832            5,345     
                                                                                                                                                      
 Net exchange gains (losses)  (1)                                                (54)                      (14)            (215)            (146)     
 Corporate expenses & net interest                                               (392)                     (320)           (1,502)          (1,418)   
 (Loss) income before income taxes from continuing operations                    $   (16)                  $  303          $ 3,115          $ 3,781   
                                                                                                                                                      
                                                                                                                                                      
                                                                                 Three Months Ended                          Year Ended                   
                                                                                 December 31,                                December 31,                 
 SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX)  (2)                                     2012                      2011            2012             2011      
 Agriculture                                                                     $   (26)                  $ (100)         $  (469)         $  (225)  
 Electronics & Communications                                                    (2)                       -               (37)             -         
 Industrial Biosciences                                                          -                         (1)             (3)              (79)      
 Nutrition & Health                                                              (36)                      (4)             (49)             (126)     
 Performance Chemicals                                                           (33)                      -               (36)             -         
 Performance Materials                                                           (3)                       47              (104)            47        
 Safety & Protection                                                             (3)                       -               (58)             -         
 Pharmaceuticals                                                                 -                         -               -                -         
 Other                                                                           11                        (10)            (126)            (28)      
 Total significant items by segment                                              $   (92)                  $   (68)        $  (882)         $  (411)  
                                                                                                                                                      
                                                                                                                                                      
                                                                                 Three Months Ended                          Year Ended                   
                                                                                 December 31,                                December 31,                 
 PTOI EXCLUDING SIGNIFICANT ITEMS                                                2012                      2011            2012             2011      
 Agriculture                                                                     $   (92)                  $ (116)         $ 2,063          $ 1,752   
 Electronics & Communications                                                    24                        42              172              355       
 Industrial Biosciences                                                          44                        34              171              78        
 Nutrition & Health                                                              66                        52              348              170       
 Performance Chemicals                                                           200                       433             1,622            1,923     
 Performance Materials                                                           254                       151             1,117            924       
 Safety & Protection                                                             88                        94              418              500       
 Pharmaceuticals                                                                 9                         89              62               289       
 Other                                                                           (71)                      (74)            (259)            (235)     
 Total Segment PTOI excluding significant items                                  $  522                    $  705          $ 5,714          $ 5,756   
                                                                                                                                                      
 (1)   See Schedule D for additional information on exchange gains and losses.                                                                                
 (2)   See Schedule B for detail of significant items.                                                                                                    


 E. I. du Pont de Nemours and Company                                                                                                                                                                                                                                                             
 
Reconciliation of Non-GAAP Measures                                                                                                                                                                                                                                                             
 
(Dollars in millions, except per share amounts)                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                
 SCHEDULE D                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                      
 Summary of Earnings Comparisons                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                
                                                                                                                                                      Three Months Ended                                                       Year Ended                                                   
                                                                                                                                                      December 31,                                                             December 31,                                                 
                                                                                                                                                  2012                           2011                      %           2012                    2011                    %        
                                                                                                                                                                                                           Change                                                      Change   
                                                                                                                                                                                                                                                                                
 Segment PTOI                                                                                                                                     $              430             $             637         -32%        $          4,832        $          5,345        -10%     
 Significant items (benefit) charge included in PTOI (per Schedule C)                                                                                   92                             68                                    882                     411                              
 Segment PTOI excluding significant items                                                                                                               $              522             $             705         -26%        $          5,714        $          5,756        -1%      
                                                                                                                                                                                                                                                                                
 Income from continuing operations after income taxes                                                                                                  $                19            $             293         -94%        $          2,493        $          3,155        -21%     
 Significant items (benefit) charge included in income from                                                                                                                                                                                                                           
 continuing operations after income taxes (per Schedule B)                                                                                            91                             (47)                                  680                     237                              
 Income from continuing operations after income taxes, excluding significant items                                                                      $              110             $             246         -55%        $          3,173        $          3,392        -6%      
                                                                                                                                                                                                                                                                                
 EPS from continuing operations                                                                                                                   $             0.02             $            0.31         -94%        $            2.61       $            3.30       -21%     
 Significant items (benefit) charge included in EPS (per Schedule B)                                                                                    0.09                           (0.05)                                0.72                    0.25                             
 EPS from continuing operations, excluding significant items                                                                                          $             0.11             $            0.26         -58%        $            3.33       $            3.55       -6%      
                                                                                                                                                                                                                                                                                
 Average number of diluted shares outstanding                                                                                                         941,219,000                    935,709,000               1%          942,197,000             941,029,000             0%       
                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                
 Reconciliation of Operating Earnings Per Share (EPS) Outlook                                                                                                                                                                                                                         
 The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs, as presented on December 13, 2012.                                                    
                                                                                                                                                                                                                                                                                  
                                                                                                                                                  Year Ended December 31,                                                                                                         
                                                                                                                                                  2013 Outlook                   2012 Actual                                                                                    
 Operating EPS                                                                                                                                    $3.85 - $4.05                  $            3.77                                                                              
                                                                                                                                                                                                                                                                                
 Significant items                                                                                                                                                                                                                                                              
 1Q 2013 U.S. tax law items retroactive to 2012 - estimate                                                                                        0.07                           -                                                                                              
 Sale of an equity method investment                                                                                                                                             0.08                                                                                           
 Customer claims charges                                                                                                                                                         (0.39)                                                                                         
 Restructuring charge/adjustments                                                                                                                                                (0.17)                                                                                         
 Litigation settlement                                                                                                                                                           (0.13)                                                                                         
 Asset impairment charge                                                                                                                                                         (0.19)                                                                                         
 Sale of business                                                                                                                                                                0.08                                                                                           
                                                                                                                                                                                                                                                                                
 Non-operating pension/OPEB costs - estimate                                                                                                      (0.42)                         (0.47)                                                                                         
                                                                                                                                                                                                                                                                                
 Impact of LIFO accounting change                                                                                                                 -                              0.03                                                                                           
                                                                                                                                                                                                                                                                                
 Reported EPS from continuing operations                                                                                                          $3.50 - $3.70                  $            2.61                                                                              


 E. I. du Pont de Nemours and Company                                                                                                                                                                                       
 
Reconciliation of Non-GAAP Measures                                                                                                                                                                                       
 
(Dollars in millions)                                                                                                                                                                                                     
                                                                                                                                                                                                              
 SCHEDULE D                                                                                                                                                                                                         
                                                                                                                                                                                                              
 Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements                                                                                                                                           
                                                                                                                                                                                                              
                                                                                                                                                Three Months Ended                  Year Ended                     
                                                                                                                                                December 31,                        December 31,                   
                                                                                                                                               2012                 2011         2012              2011       
                                                                                                                                                                                                              
 (Loss) income from continuing operations before income taxes                                                                                  $    (16)            $    303     $   3,115         $   3,781  
 Less: Net income attributable to noncontrolling interests                                                                                          1                    4            25                36         
 Add:   Interest expense                                                                                                                       117                  116          464               447        
 Adjusted EBIT from continuing operations                                                                                                      100                  415          3,554             4,192      
 Add: Depreciation and amortization                                                                                                            394                  393          1,631             1,451      
 Adjusted EBITDA from continuing operations                                                                                                    $    494             $    808     $   5,185         $   5,643  
                                                                                                                                                                                                              
                                                                                                                                                                                                              
                                                                                                                                                                                                                
 Calculation of Free Cash Flow - Total Company                                                                                                                                                                             
                                                                                                                                                                                                              
                                                                                                                                               Year Ended                                                       
                                                                                                                                               December 31,                                                     
                                                                                                                                                                                 
                                                                                                                                               2012                 2011                                      
 Cash provided by (used for) operating activities                                                                                              $ 4,849              $ 5,152                                   
 Less: Purchases of property, plant and equipment                                                                                              1,793                1,843                                     
 Free cash flow                                                                                                                                $ 3,056              $ 3,309                                   
                                                                                                                                                                                                              
                                                                                                                                                                                                              


 E. I. du Pont de Nemours and Company                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 
Reconciliation of Non-GAAP Measures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 
(Dollars in millions)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 SCHEDULE D (continued)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 Exchange Gains/Losses                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated Income Statements.            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                    Three Months Ended                                                                                                                                                                    Year Ended                                                                                                                               
                                                                                                                                                                                                                                                                    
December 31,                                                                                                                                                                         December 31,                                                                                                                             
                                                                                                                                                                                                                                                                    2012                                                                                      2011                                                                                      2012                                                                                      2011                                         
 Subsidiary/Affiliate Monetary Position Gain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 (Loss)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 Pre-tax exchange gains (losses) (includes                                                                                                                                                                                                                          $         (8)                                                                             $        (83)                                                                             $       (58)                                                                              $        (13)                                
 equity affiliates)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 Local tax benefits (expenses)                                                                                                                                                                                                                                      9                                                                                         4                                                                                         19                                                                                        35                                           
 Net after-tax impact from subsidiary                                                                                                                                                                                                                               $           1                                                                             $        (79)                                                                             $       (39)                                                                              $          22                                
 exchange gains (losses)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 Hedging Program Gain (Loss)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 Pre-tax exchange gains (losses)                                                                                                                                                                                                                                    $       (46)                                                                              $          69                                                                             $     (157)                                                                               $      (133)                                 
 Tax benefits (expenses)                                                                                                                                                                                                                                            16                                                                                        (24)                                                                                      54                                                                                        46                                           
 Net after-tax impact from hedging program                                                                                                                                                                                                                          $       (30)                                                                              $          45                                                                             $     (103)                                                                               $        (87)                                
 exchange gains (losses)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 Total Exchange Gain (Loss)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 Pre-tax exchange gains (losses)                                                                                                                                                                                                                                    $       (54)                                                                              $        (14)                                                                             $     (215)                                                                               $      (146)                                 
 Tax benefits (expenses)                                                                                                                                                                                                                                            25                                                                                        (20)                                                                                      73                                                                                        81                                           
 Net after-tax exchange gains (losses)  (1)                                                                                                                                                                                                                         $       (29)                                                                              $        (34)                                                                             $     (142)                                                                               $        (65)                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 (1)  The above Net after-tax exchange gains (losses) excludes gains (losses) attributable to discontinued operations of $(3) and $(5) for the three months ended December 31, 2012 and 2011, respectively, and $(14) and $(17) for the year ended December 31, 2012 and 2011, respectively.                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
 Reconciliation of Base Income Tax Rate to Effective Income Tax Rate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 Base income tax rate is defined as the effective income tax rate less the effect of exchange gains/losses, as defined above, and significant items.                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                    Three Months Ended                                                                                                                                                                    Year Ended                                                                                                                               
                                                                                                                                                                                                                                                                    
December 31,                                                                                                                                                                         December 31,                                                                                                                             
                                                                                                                                                                                                                                                                    2012                                                                                      2011                                                                                      2012                                                                                      2011                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 (Loss) income from continuing operations                                                                                                                                                                                                                           $       (16)                                                                              $        303                                                                              $    3,115                                                                                $     3,781                                  
 before income taxes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 Add:  Significant items - (benefit) charge                                                                                                                                                                                                                         117                                                                                       68                                                                                        966                                                                                       467                                          
 (2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 Less:  Net exchange (losses) gains                                                                                                                                                                                                                                 (54)                                                                                      (14)                                                                                      (215)                                                                                     (146)                                        
 Income from continuing operations before income taxes, significant items and exchange                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 gains/losses                                                                                                                                                                                                                                                       $       155                                                                               $        385                                                                              $    4,296                                                                                $     4,394                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 (Benefit from) provision for income taxes on                                                                                                                                                                                                                        $       (35)                                                                              $          10                                                                             $       622                                                                               $        626                                 
 continuing operations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 Add:  Tax benefit (expenses) on significant                                                                                                                                                                                                                        26                                                                                        115                                                                                       286                                                                                       230                                          
 items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 Tax benefits (expenses) on exchange gains/losses                                                                                                                                                                                                                     25                                                                                        (20)                                                                                      73                                                                                        81                                           
 Provision for income taxes on continuing operations, excluding taxes on significant items                                                                                                                                                                              $         16                                                                              $        105                                                                              $       981                                                                               $        937                                 
       and exchange gains/losses                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 Effective income tax rate                                                                                                                                                                                                                                          218.8%                                                                                    3.3%                                                                                      20.0%                                                                                     16.6%                                        
 Significant items effect                                                                                                                                                                                                                                           (227.7%)                                                                                  30.4%                                                                                     2.2%                                                                                      3.6%                                         
 Tax rate, from continuing operations, before                                                                                                                                                                                                                        (8.9%)                                                                                    33.7%                                                                                     22.2%                                                                                     20.2%                                        
 significant items                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 Exchange gains (losses) effect                                                                                                                                                                                                                                     19.2%                                                                                     (6.4%)                                                                                    0.6%                                                                                      1.1%                                         
 Base income tax rate from continuing                                                                                                                                                                                                                               10.3%                                                                                     27.3%                                                                                     22.8%                                                                                     21.3%                                        
 operations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 (2)  See Schedule B for detail of                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 significant items.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            


 E. I. du Pont de Nemours and Company                                                                                               
 
Consolidated Segment Information                                                                                                  
 
(Dollars in millions)                                                                                                             
                                                                                                                             
 SCHEDULE E                                                                                                                     
 Below represents the company's estimated 4Q and Full Year 2012 segment operating earnings reflecting the change in reporting for the cost of non-operating pension and other post-employment benefits and excluding significant items. 
                                                                                                                             
                                                                                                                             
                                                            Three Months Ended                     Year Ended                
                                                            December 31,                           December 31,              
 SEGMENT OPERATING EARNINGS                                 2012                                   2012                      
 Agriculture                                                $                             (78)     $           2,138         
 Electronics & Communications                               43                                     259                       
 Industrial Biosciences                                     42                                     162                       
 Nutrition & Health                                         58                                     326                       
 Performance Chemicals                                      237                                    1,814                     
 Performance Materials                                      273                                    1,225                     
 Safety & Protection                                        133                                    620                       
 Pharmaceuticals                                            9                                      62                        
 Other                                                      (101)                                  (355)                     
 Total Segment Operating Earnings                           616                                    6,251                     
                                                                                                                             
 Significant items benefit (charge)(1)                      (92)                                   (882)                     
 Non-operating pension/OPEB costs                           (144)                                  (615)                     
 LIFO/Other reporting changes                               50                                     78                        
 Total Segment PTOI                                         $                             430      $           4,832         
                                                                                                                             
                                                                                                                             
 (1)   See Schedule B for detail of significant items.                                                                         


SOURCE  DuPont


Media Contact: Michael Hanretta, +1-302-774-4005,
michael.j.hanretta@usa.dupont.com; Investor Contact: +1-302-774-4994

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.